FindTrial
Sign In

Benefits of topical application of insulin in Diabetic foot ulcer.

Benefits of Topical insulin in diabetic foot ulcer: Study in Tertiary Care centre of Southern Odisha - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082103
Enrollment
90
Registered
2025-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E086- Diabetes mellitus due to underlying condition with other specified complications

Interventions

Intervention1: Mixtrad insulin: Topical application in dressing of diabetic foot ulcer. Alternate day dressing for 14 days. 4 unit mixtrad insulin in 1ml NS. Sterile gauze 10ml per 10cm2 of ulcer to

Sponsors

Mkcg medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic foot ulcer

Exclusion criteria

Exclusion criteria: Active Osteomyelitis HIV/ HBsAg positive Denied consent Severe anemia Occlusion of major vessel of leg

Design outcomes

Primary

MeasureTime frame
Early granulation Complete primary healingTimepoint: 0 7, 15 days—

Secondary

MeasureTime frame
Better graft uptake Low infection rate Decreased hospital stayTimepoint: 0, 7 15 days—

Countries

India

Contacts

Public ContactDr Biswajita Rautaray

Department of General Surgery.MKCG Medical college and Hospital

rautaraybiswajita@gmail.com7978183406

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026